首页 | 本学科首页   官方微博 | 高级检索  
     


Paradoxical simultaneous regression and progression of lesions in a phase II study of everolimus in classic Kaposi sarcoma
Authors:S. Mourah  R. Porcher  M. Battistella  D. Kerob  B. Guillot  T. Jouary  F. Agbalika  F. Morinet  V. Furlan  H.M. Teisserenc  N. Dupin  C. Lebbé
Affiliation:1. APHP, Pharmacology–Genetic Laboratory, Saint Louis Hospital, INSERM U976, Paris, France;2. APHP, Hotel Dieu Hospital, Centre for Clinical Epidemiology, University Paris Diderot, Paris, France;3. APHP, Department of Pathology, Saint Louis Hospital, INSERM U1165, Paris, France;4. APHP, Department of Dermatology, Saint Louis Hospital, Paris, France;5. Department of Dermatology, Montpellier University Hospital, INSERM U1058, Montpellier, France;6. Skin Cancer Unit, Dermatology Department, Bordeaux University Hospital, Bordeaux, France;7. APHP, Virology Unit, Microbiology Department, Saint Louis Hospital, Paris, France;8. APHP, CITOH, Saint Louis Hospital, Paris, France;9. APHP Toxicology Laboratory, Hospital Kremlin Bicêtre, Le Kremlin, Bicêtre, France;10. APHP, Immunology and Histocompatibility Laboratory, Saint Louis Hospital, University Paris Diderot, INSERM UMR1160, Paris, France;11. Dermatology Department, Cochin Hospital, Paris Sorbonne University, INSERM U101675014, Paris, France;12. University Paris Diderot, INSERM U976, Paris, France
Abstract:
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号